Rapporten
Verifierade nyheter om finansiering, huvudkontor och ledarskap från världens mest innovativa företag
3 rapporter och fler
Breye Therapeutics Raises €67.5M Series A for Oral Retinal Disease Drugs
Breye Therapeutics raised an over-subscribed €67.5 million Series A co-led by Mission BioCapital and Novo Holdings to advance danegaptide into a Phase 2 trial.
SpyGlass Pharma Opens New Headquarters in Irvine
SpyGlass Pharma opened a 33,000-square-foot headquarters in Irvine, California, on August 27, 2026, moving from its former facility in Aliso Viejo as it prepares for its first product launch.
Aldeyra Therapeutics Headquarters - Office Location & Address
Discover Aldeyra Therapeutics's headquarters at 131 Hartwell Ave, Lexington, MA 02421. Ophthalmology therapeutics developer. Learn about the office facilities and work environment.
Visar 3 rapporter • Sida 1 • Kategori: all
Ligga steget före marknaden
Få veckovisa insikter levererade till din inkorg. Ingen spam, bara intelligens.